BibTex RIS Cite

The Management of Constipation Developed Due To The Use of Opioids In The Management of Cancer Pain

Year 2018, Issue: 2, 105 - 109, 01.06.2018

Abstract

Today, the use of opioids in the management of cancer pain is very common. Opioids have side effects that affect daily lives of the patients as in other treatments. One of the most common side effects is constipation. Although evaluation of the symptom is important, there are options for managing constipation with pharmacological and non-pharmacological methods. In this review, current treatment and care methods were discussed in order to increase the health professionals’ awareness

References

  • Paice JA, Ferrel B. The management of cancer pain. CA Cancer J Clin 2011;61:157–82. https://doi.org/10.3322/caac.20112
  • World Health Organization. Palliative care. Fact sheet, reviewed August 2017. Available at: http://www.who.int/mediacentre/ factsheets/fs402/en/
  • Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F; ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23:vii139–54. https:// doi.org/10.1093/annonc/mds233
  • van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437–49. https://doi.org/10.1093/annonc/mdm056
  • van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten BE, Tjan-Heijnen VC, Janssen DJ. Update on Prevalence of Pain in Patients with Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage 2016;51:1070–90. https://doi.org/10.1016/j. jpainsymman.2015.12.340
  • Uzunoğlu S, Çiçin İ. Kanser Hastalarında Ağrıya Yaklaşım. Klinik Gelişim 2011;24:14–20.
  • Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence- based recommendations from the EAPC. Lancet Oncol 2012;13:e58– 68. https://doi.org/10.1016/S1470-2045(12)70040-2
  • Sarıhan E, Kadıoğlu E, İğde FA. Kanser Ağrısı, Tedavi Prensipleri ve Dünya Sağlık Örgütü Ağrı Basamak Tedavisi. Nobel Med 2012;8:5–15.
  • Arslan D, Tatlı AM, Üyetürk Ü. Kansere Bağlı Ağrı ve Tedavisi. Abant Med J 2013;2:256–60.
  • Poulsen JL, Brock C, Olesen AE, Nilsson M, Drewes AM. Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therap Adv Gastroenterol 2015;8:360–72. https://doi. org/10.1177/1756283X15589526
  • Kayhan GE, Gülhaş N, Aslan A, Durmuş M. Algoloji Polikliniğine Başvuran Onkolojik Hastalarda Tedavi ve Komplikasyon Yönetimi: Retrospektif Değerlendirme. J Turgut Ozal Med Cent 2013:20:50–4.
  • Christo PJ. Opioid effectiveness and side effects in chronic pain. Anesthesiol Clin North America 2003;21:699–713.
  • Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician 2006;74:1347–54.
  • Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician 2008;11:S105–20.
  • Boland J, Boland E, Brooks D. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients andtitration of naloxone. Clin Med (Lond) 2013;13:149–51. https:// doi.org/10.7861/clinmedicine.13-2-149
  • Oosten AW, Oldenmenger WH, Mathijssen RH, van der Rijt CC. A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures. J Pain 2015;16:935–46. https://doi.org/10.1016/j.jpain.2015.05.006
  • Şenel G. Opioid Değişimi ve Opioid Yan Etkilerinin Yönetimi. Ankara, 2016. Erişim: http://kanser.gov.tr/Dosya/GulcinsENEL.pdf
  • Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 2011;106:835–42. https://doi.org/10.1038/ajg.2011.30
  • Drewes AM, Munkholm P, Simrén M, Breivik H, Kongsgaard UE, Hatlebakk JG, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction –Recommendations of the Nordic Working Group. Scand J Pain 2016;11:111–22. https://doi. org/10.1016/j.sjpain.2015.12.005
  • Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010;22:424–30. https://doi.org/10.1111/j.1365-2982.2009.01458.x
  • Hjalte F, Berggren AC, Bergendahl H, Hjortsberg C. The direct and indirect costs of opioid-induced constipation. J Pain Symptom Manage 2010;40:696–703. https://doi.org/10.1016/j. jpainsymman.2010.02.019
  • Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, et al. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage 2010;40:761–73. https://doi.org/10.1016/j. jpainsymman.2010.03.026
  • Special Disease State Report. The Impact of Opioid-Induced Constipation (OIC) in Patients Receiving Opioids. April, 2015. Available at: http://www.jmcp.org/pb-assets/Outserts/April2015. pdf
  • Christensen HN, Olsson U, From J, Breivik H. Opioid-induced constipation, use of laxatives, and health-related quality of life. Scand J Pain 2016;11:104–10. https://doi.org/10.1016/j.sjpain.2015.12.007
  • Ünsar ST, Şenses A, Karadakovan A. Aydıner A. Diyare ve konstipasyon. Can G, editör. Onkoloji Hemşireliğinde Kanıttan Uygulamaya - Konsensus 2014. İstanbul: Nobel Tıp Kitapevleri; 2015. s. 159–71.
  • Bengi G, Yalçın M, Akpınar H. Kronik konstipasyona güncel yaklaşım. Güncel Gastroentoloji 2014;18:72–88.
  • Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol 2014;32:1662–70. https://doi.org/10.1200/JCO.2013.52.5188
  • Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage 2012;43:306– 13. https://doi.org/10.1016/j.jpainsymman.2011.12.002
  • Kara H. Laksatif ve Pürgatifler. Güncel Gastroentoloji 2015;19:30–3.
  • Gyawali B, Hayashi N, Tsukuura H, Honda K, Shimokata T, Ando Y. Opioid-induced constipation. Scand J Gastroenterol 2015;50:1331– 8. https://doi.org/10.3109/00365521.2015.1054423
  • Ahmedzai SH, Leppert W, Janecki M, Pakosz A, Lomax M, Duerr H, Hopp M. Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Support Care Cancer 2015;23:823–30. https:// doi.org/10.1007/s00520-014-2435-5
  • Nelson AD, Camilleri M. Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis 2016;7:121–34. https://doi. org/10.1177/2040622315627801
  • Mehta N, O’Connell K, Giambrone GP, Baqai A, Diwan S. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Postgrad Med 2016;128:282– 9. https://doi.org/10.1080/00325481.2016.1149017

Kanser Ağrısının Yönetiminde Opioidlerin Kullanımına Bağlı Gelişen Konstipasyonun Yönetimi

Year 2018, Issue: 2, 105 - 109, 01.06.2018

Abstract

Günümüzde kanser ağrısının yönetiminde opioidlerin kullanımı oldukça yaygındır. Opioidlerin diğer ilaç tedavilerinde olduğu gibi bireyin günlük yaşam aktivitelerini etkileyecek boyutta ortaya çıkardığı yan etkiler bulunmaktadır. En sık görülen yan etkilerden birisi konstipasyondur. Semptomun değerlendirilmesi önemli olmakla birlikte, farmakolojik ve farmakolojik olmayan yöntemlerle yönetimi için pek çok seçenek bulunmaktadır. Bu derlemede, sağlık profesyonelinin farkındalığının arttırılması amacıyla, güncel tedavi ve bakım anlayışlarına yer verilmiştir

References

  • Paice JA, Ferrel B. The management of cancer pain. CA Cancer J Clin 2011;61:157–82. https://doi.org/10.3322/caac.20112
  • World Health Organization. Palliative care. Fact sheet, reviewed August 2017. Available at: http://www.who.int/mediacentre/ factsheets/fs402/en/
  • Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F; ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23:vii139–54. https:// doi.org/10.1093/annonc/mds233
  • van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437–49. https://doi.org/10.1093/annonc/mdm056
  • van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten BE, Tjan-Heijnen VC, Janssen DJ. Update on Prevalence of Pain in Patients with Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage 2016;51:1070–90. https://doi.org/10.1016/j. jpainsymman.2015.12.340
  • Uzunoğlu S, Çiçin İ. Kanser Hastalarında Ağrıya Yaklaşım. Klinik Gelişim 2011;24:14–20.
  • Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence- based recommendations from the EAPC. Lancet Oncol 2012;13:e58– 68. https://doi.org/10.1016/S1470-2045(12)70040-2
  • Sarıhan E, Kadıoğlu E, İğde FA. Kanser Ağrısı, Tedavi Prensipleri ve Dünya Sağlık Örgütü Ağrı Basamak Tedavisi. Nobel Med 2012;8:5–15.
  • Arslan D, Tatlı AM, Üyetürk Ü. Kansere Bağlı Ağrı ve Tedavisi. Abant Med J 2013;2:256–60.
  • Poulsen JL, Brock C, Olesen AE, Nilsson M, Drewes AM. Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therap Adv Gastroenterol 2015;8:360–72. https://doi. org/10.1177/1756283X15589526
  • Kayhan GE, Gülhaş N, Aslan A, Durmuş M. Algoloji Polikliniğine Başvuran Onkolojik Hastalarda Tedavi ve Komplikasyon Yönetimi: Retrospektif Değerlendirme. J Turgut Ozal Med Cent 2013:20:50–4.
  • Christo PJ. Opioid effectiveness and side effects in chronic pain. Anesthesiol Clin North America 2003;21:699–713.
  • Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician 2006;74:1347–54.
  • Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician 2008;11:S105–20.
  • Boland J, Boland E, Brooks D. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients andtitration of naloxone. Clin Med (Lond) 2013;13:149–51. https:// doi.org/10.7861/clinmedicine.13-2-149
  • Oosten AW, Oldenmenger WH, Mathijssen RH, van der Rijt CC. A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures. J Pain 2015;16:935–46. https://doi.org/10.1016/j.jpain.2015.05.006
  • Şenel G. Opioid Değişimi ve Opioid Yan Etkilerinin Yönetimi. Ankara, 2016. Erişim: http://kanser.gov.tr/Dosya/GulcinsENEL.pdf
  • Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 2011;106:835–42. https://doi.org/10.1038/ajg.2011.30
  • Drewes AM, Munkholm P, Simrén M, Breivik H, Kongsgaard UE, Hatlebakk JG, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction –Recommendations of the Nordic Working Group. Scand J Pain 2016;11:111–22. https://doi. org/10.1016/j.sjpain.2015.12.005
  • Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010;22:424–30. https://doi.org/10.1111/j.1365-2982.2009.01458.x
  • Hjalte F, Berggren AC, Bergendahl H, Hjortsberg C. The direct and indirect costs of opioid-induced constipation. J Pain Symptom Manage 2010;40:696–703. https://doi.org/10.1016/j. jpainsymman.2010.02.019
  • Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, et al. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage 2010;40:761–73. https://doi.org/10.1016/j. jpainsymman.2010.03.026
  • Special Disease State Report. The Impact of Opioid-Induced Constipation (OIC) in Patients Receiving Opioids. April, 2015. Available at: http://www.jmcp.org/pb-assets/Outserts/April2015. pdf
  • Christensen HN, Olsson U, From J, Breivik H. Opioid-induced constipation, use of laxatives, and health-related quality of life. Scand J Pain 2016;11:104–10. https://doi.org/10.1016/j.sjpain.2015.12.007
  • Ünsar ST, Şenses A, Karadakovan A. Aydıner A. Diyare ve konstipasyon. Can G, editör. Onkoloji Hemşireliğinde Kanıttan Uygulamaya - Konsensus 2014. İstanbul: Nobel Tıp Kitapevleri; 2015. s. 159–71.
  • Bengi G, Yalçın M, Akpınar H. Kronik konstipasyona güncel yaklaşım. Güncel Gastroentoloji 2014;18:72–88.
  • Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol 2014;32:1662–70. https://doi.org/10.1200/JCO.2013.52.5188
  • Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage 2012;43:306– 13. https://doi.org/10.1016/j.jpainsymman.2011.12.002
  • Kara H. Laksatif ve Pürgatifler. Güncel Gastroentoloji 2015;19:30–3.
  • Gyawali B, Hayashi N, Tsukuura H, Honda K, Shimokata T, Ando Y. Opioid-induced constipation. Scand J Gastroenterol 2015;50:1331– 8. https://doi.org/10.3109/00365521.2015.1054423
  • Ahmedzai SH, Leppert W, Janecki M, Pakosz A, Lomax M, Duerr H, Hopp M. Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Support Care Cancer 2015;23:823–30. https:// doi.org/10.1007/s00520-014-2435-5
  • Nelson AD, Camilleri M. Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis 2016;7:121–34. https://doi. org/10.1177/2040622315627801
  • Mehta N, O’Connell K, Giambrone GP, Baqai A, Diwan S. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Postgrad Med 2016;128:282– 9. https://doi.org/10.1080/00325481.2016.1149017
There are 33 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Elif Sözeri

Sevinç Kutluturkan

Publication Date June 1, 2018
Published in Issue Year 2018Issue: 2

Cite

EndNote Sözeri E, Kutluturkan S (June 1, 2018) Kanser Ağrısının Yönetiminde Opioidlerin Kullanımına Bağlı Gelişen Konstipasyonun Yönetimi. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 2 105–109.